Pacific Biosciences of California, Inc. (BMV:PACB)

Market Cap	8.00B
Revenue (ttm)	3.11B
Net Income (ttm)	-13.44B
Shares Out	n/a
EPS (ttm)	-47.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,889
Average Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	22.22 - 22.22
Beta	n/a
RSI	n/a
Earnings Date	Aug 7, 2025

About Hess Corporation

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified ...

• Industry: Laboratory Analytical Instruments
• Founded: 2000
• Employees: 575
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PACB

Financial Performance

In 2024, BMV:PACB's revenue was $154.01 million, a decrease of -23.19% compared to the previous year's $200.52 million. Losses were -$309.85 million, 1.02% more than in 2023.

Financial numbers in BGN